Day One Biopharmaceuticals (DAWN) Return on Assets: 2024-2025
Historic Return on Assets for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Sep 2025 value amounting to -0.29%.
- Day One Biopharmaceuticals' Return on Assets rose 9.00% to -0.29% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.29%, marking a year-over-year increase of 9.00%. This contributed to the annual value of -0.43% for FY2024, which is 9.00% up from last year.
- As of Q3 2025, Day One Biopharmaceuticals' Return on Assets stood at -0.29%, which was down 60.89% from -0.18% recorded in Q2 2025.
- In the past 5 years, Day One Biopharmaceuticals' Return on Assets registered a high of -0.18% during Q2 2025, and its lowest value of -0.76% during Q2 2024.
- Its 2-year average for Return on Assets is -0.41%, with a median of -0.35% in 2024.
- Data for Day One Biopharmaceuticals' Return on Assets shows a peak YoY soared of 58bps (in 2025) over the last 5 years.
- Quarterly analysis of 2 years shows Day One Biopharmaceuticals' Return on Assets stood at -0.35% in 2024, then rose by 9bps to -0.29% in 2025.
- Its Return on Assets stands at -0.29% for Q3 2025, versus -0.18% for Q2 2025 and -0.32% for Q1 2025.